mastercontrol.com
Playbook cross-references FDA guidance publications with SOP categories for sterile injectable manufacturers and analyzes 483 observations to surface CAPA failure patterns and regulatory change impacts.
adlibsoftware.com
The playbook cross-references FDA 510k refusal deficiencies with open QSR violations to identify the exact document control gaps blocking device clearance, while targeting CROs with accelerating clinical trial enrollment for document intake bottlenecks.
View Playbook →advancedmd.com
The playbook uses SAMHSA facility directories and CARF accreditation databases to identify behavioral health facilities with upcoming accreditation renewals, delivering documentation gap checklists mapped to CARF 2024 standards.
View Playbook →advanstar.com
The playbook monitors FDA Drug Master File filings and EMA GMP certifications in real-time to surface newly qualified API suppliers and contract manufacturers before they appear at trade shows, giving procurement teams a market entry advantage.
View Playbook →archy.com
The playbook mines internal claims data to identify DSOs with high denial rates on specific procedure codes by state, cross-referencing against Texas Medicaid documentation requirement changes to surface recoverable revenue in appeals.
View Playbook →aspirepharma.co.uk
The playbook cross-references internal NICE appraisal pipeline timelines against NHS trust tender schedules to identify procurement windows that will lock in old formulations before improved versions receive approval, preventing 18-24 month supply chain errors.
View Playbook →arcgis.com
The playbook uses HRSA UDS reports and CMS quality data to identify FQHCs with expanding patient volume but worsening days-in-AR, and ASCs with declining quality scores plus recent inspection deficiencies creating dual reimbursement and license risk.
View Playbook →